Aimei Health Technology Co., Ltd
Price Action
Technical Summary
EMERGING TRENDAimei Health Technology Co., Ltd is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 97), indicating clear outperformance against the broad market. Earnings contraction of 59% provides fundamental context to the price action. However, price is extended 20% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $45.67 | -6.56% | BELOW |
| 50 SMA | $35.54 | +20.06% | ABOVE |
| 100 SMA | $42.99 | -0.73% | BELOW |
| 150 SMA | $33.23 | +28.43% | ABOVE |
| 200 SMA | $27.74 | +53.85% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is AFJK in an uptrend right now?
AFJK has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is AFJK overbought or oversold?
AFJK's RSI (14) is 54. The stock is in neutral territory, neither overbought nor oversold.
Is AFJK outperforming the market?
AFJK has a Relative Strength (RS) Rating of 97 out of 99. Yes, AFJK is a market leader, outperforming 97% of all stocks over the past 12 months.
Where is AFJK in its 52-week range?
AFJK is trading at $42.67, which is 33% of its 52-week high ($130.37) and 29% above its 52-week low ($6.75).
How volatile is AFJK?
AFJK has a Beta of 0.23 and 52-week volatility of 169%. It's less volatile than the S&P 500 - generally more stable.